non-alcoholic steatohepatitis
- Business
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
Copenhagen, Denmark & Ingelheim, Germany: New studies mark an important advancement of Boehringer Ingelheim’s cardiometabolic focus areas obesity and NASH.…
Read More » - Technology
LG Chem Life Sciences Announces First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States
Nanjing, China & Seoul, South Korea & Cambridge, Mass., United States: LG Chem licensed LG00303174 (TT-01025) from TransThera Biosciences Co.…
Read More » - World
LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 Inhibitor
Nanjing, China & Seoul, Korea: LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co.…
Read More »